CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics Revenue

CytomX Therapeutics had revenue of $18.66M in the quarter ending June 30, 2025, a decrease of -25.71%. This brings the company's revenue in the last twelve months to $141.10M, up 18.01% year-over-year. In the year 2024, CytomX Therapeutics had annual revenue of $138.10M with 36.45% growth.

• Revenue (ttm): $141.10M
• Revenue Growth: +18.01%
• P/S Ratio: 2.28
• Revenue / Employee: $1,166,116
• Employees: 121
• Market Cap: 549.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	138.10M	36.89M	36.45%
Dec 31, 2023	101.21M	48.05M	90.38%
Dec 31, 2022	53.16M	15.85M	42.48%
Dec 31, 2021	37.31M	-31.12M	-45.47%
Dec 31, 2020	68.43M	41.53M	154.36%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.